MCID: HYP057
MIFTS: 36

Hypervitaminosis D malady

Category: Metabolic diseases

Aliases & Classifications for Hypervitaminosis D

About this section

Aliases & Descriptions for Hypervitaminosis D:

Name: Hypervitaminosis D 10 12 65

Classifications:



External Ids:

Disease Ontology10 DOID:9971
ICD1027 E67.3
SNOMED-CT59 190969000, 27712000
ICD9CM29 278.4
UMLS65 C1442839

Summaries for Hypervitaminosis D

About this section
MalaCards based summary: Hypervitaminosis D is related to dementia and diabetic angiopathy. An important gene associated with Hypervitaminosis D is PTH (Parathyroid Hormone), and among its related pathways are Osteoblast Signaling and Nuclear receptors in lipid metabolism and toxicity. Affiliated tissues include kidney, bone and breast, and related mouse phenotypes are craniofacial and digestive/alimentary.

Related Diseases for Hypervitaminosis D

About this section

Diseases in the Hypervitaminosis D family:

Hypervitaminosis a

Diseases related to Hypervitaminosis D via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 120)
idRelated DiseaseScoreTop Affiliating Genes
1dementia29.7FGF23, PTH, VDR
2diabetic angiopathy10.2FGF23, PTH
3testicular microlithiasis10.1FGF23, PTH
4colorectal cancer10.1
5prostate cancer10.1
6thrombocytopenia10.1
7sarcoma10.1
8prostatitis10.1
9pancreatitis10.1
10endotheliitis10.1
11epidermolysis bullosa, pretibial10.1FGF23, PTH
12dominant beta-thalassemia10.1TRPV5, VDR
13chromosomal disease10.1PTH, VDR
14restless legs syndrome 110.0CYP27B1, VDR
15primary bacterial infectious disease10.0FGF23, PTH
16thymus mucoepidermoid carcinoma10.0PTH, VDR
17calcium metabolism disease10.0FGF23, VDR
18schizophrenia10.0
19rheumatoid arthritis10.0
20neuroblastoma10.0
21systemic lupus erythematosus10.0
22hiv-110.0
23fumarase deficiency10.0
24tetralogy of fallot10.0
25costello syndrome10.0
26pancreatic cancer10.0
27panic disorder10.0
28hemochromatosis10.0
29amelogenesis imperfecta10.0
30arthritis10.0
31atherosclerosis10.0
32bipolar disorder10.0
33brain injury10.0
34burns10.0
35crohn's disease10.0
36follicular lymphoma10.0
37leber congenital amaurosis10.0
38primary biliary cirrhosis10.0
39spondylolisthesis10.0
40swine influenza10.0
41chorioamnionitis10.0
42artery disease10.0
43oral squamous cell carcinoma10.0
44peripheral neuropathy10.0
45lymphoma10.0
46tropical sprue10.0
47open-angle glaucoma10.0
48filariasis10.0
49cornelia de lange syndrome10.0
50hiatus hernia10.0

Graphical network of the top 20 diseases related to Hypervitaminosis D:



Diseases related to hypervitaminosis d

Symptoms for Hypervitaminosis D

About this section

Drugs & Therapeutics for Hypervitaminosis D

About this section

Drugs for Hypervitaminosis D (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 15)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Ergocalciferolapproved, nutraceuticalPhase 4, Phase 3, Phase 292350-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
2
Cholecalciferolapproved, nutraceuticalPhase 4, Phase 3, Phase 279967-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
3Bone Density Conservation AgentsPhase 4, Phase 3, Phase 22600
4vitamin dPhase 4, Phase 3, Phase 21524
5VitaminsPhase 4, Phase 3, Phase 23857
6MicronutrientsPhase 4, Phase 3, Phase 23901
7Trace ElementsPhase 4, Phase 3, Phase 23900
8ErgocalciferolsPhase 4, Phase 3, Phase 2923
9HydroxycholecalciferolsPhase 492
10CalciferolNutraceuticalPhase 4, Phase 3, Phase 21074
11Vitamin D2NutraceuticalPhase 4, Phase 3, Phase 2923
12Pharmaceutical SolutionsPhase 27004
13HepcidinsPhase 249
14Calcium, Dietary4678
15OliveNutraceutical235

Interventional clinical trials:

idNameStatusNCT IDPhase
1The Effect of Supplementation With Two Different Doses of Vitamin D on Bone Mineral Density, Vitamin D Levels and Hand Grip Strength in Children With Diabetes Mellitus Type 1CompletedNCT01277913Phase 4
2Randomized Study of Two Vitamin D Dosing Strategies in Children With Chronic Kidney DiseaseActive, not recruitingNCT01909115Phase 3
3Prevention of Vitamin D Deficiency Following Pediatric CHD Surgery: a Phase II Dose Evaluation Randomized Controlled Trial Comparing Usual Care With a High Dose Pre-operative Supplementation Regimen Based on the Institute of Medicine Daily Upper TolerableCompletedNCT01838447Phase 2
4Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney DiseaseRecruitingNCT01532349Phase 2
5Efficacy of Vitamin D Therapy on Glucose Homeostasis in Obese AdolescentsCompletedNCT02414529
6Change in Free 25(OH)D After High Dose in Vitamin D Deficient Postmenopausal WomenRecruitingNCT02553044
7Vitamin D Supplements on Markers for Cardiovascular Disease and Diabetes: an Individual Participant Data Meta-analysisActive, not recruitingNCT02551835

Search NIH Clinical Center for Hypervitaminosis D

Genetic Tests for Hypervitaminosis D

About this section

Anatomical Context for Hypervitaminosis D

About this section

MalaCards organs/tissues related to Hypervitaminosis D:

33
Kidney, Bone, Breast, Myeloid, Endothelial, T cells, Tongue

Animal Models for Hypervitaminosis D or affiliated genes

About this section

MGI Mouse Phenotypes related to Hypervitaminosis D:

38 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053828.3CYP27B1, GALNT3, PTH, VDR
2MP:00053818.0FGF23, GALNT3, KL, TRPV5, VDR
3MP:00107717.9CYP27B1, FGF23, GALNT3, KL, VDR
4MP:00053897.9CYP27B1, FGF23, GALNT3, KL, VDR
5MP:00053797.6CYP27B1, FGF23, GALNT3, KL, PTH, VDR
6MP:00053717.5CYP27B1, FGF23, GALNT3, KL, PTH, VDR
7MP:00053677.4CYP27B1, FGF23, GALNT3, KL, TRPV5, VDR
8MP:00053857.2CYP27B1, FGF23, GALNT3, KL, PTH, VDR
9MP:00053766.9CYP27B1, FGF23, GALNT3, KL, PTH, TRPV5
10MP:00053786.9CYP27B1, FGF23, GALNT3, KL, PTH, TRPV5
11MP:00053906.7CYP27B1, FGF23, GALNT3, KL, PTH, TRPV5
12MP:00053876.6CYP27B1, FGF23, GALNT3, KL, PTH, TRPV5
13MP:00053976.4CYP27B1, FGF23, GALNT3, KL, PTH, TRPV5

Publications for Hypervitaminosis D

About this section

Articles related to Hypervitaminosis D:

(show top 50)    (show all 112)
idTitleAuthorsYear
1
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. (23918834)
2014
2
AAG8 promotes carcinogenesis by activating STAT3. (24726897)
2014
3
A lifetime of hypercalcemia and hypercalciuria, finally explained. (24423361)
2014
4
The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotype. (24445246)
2014
5
Plasma cell (Zoon) balanitis: another inflammatory disorder that can be rich in IgG4+ plasma cells. (25216321)
2014
6
Drilling juvenile osteochondritis dissecans: retro- or transarticular? (22274726)
2013
7
Classification and natural history of the neuronal ceroid lipofuscinoses. (23838030)
2013
8
Lipoma of the colon: should asymptomatic tumors be treated? (23317607)
2013
9
Inhibiting glycogen synthesis prevents lafora disease in a mouse model. (23913475)
2013
10
Relationship of Trauma Exposure and Substance Abuse to Self-Reported Violence Among Men and Women in Substance Abuse Treatment. (24323693)
2013
11
Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. (23334981)
2013
12
Dextrocardia, atrial septal defect, severe developmental delay, facial anomalies, and supernumerary ribs in a child with a complex unbalanced 8;22 translocation including partial 8p duplication. (22302699)
2012
13
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers? (22113258)
2012
14
Aspiration pneumonia and death in Huntington's disease. (22307361)
2012
15
p63 expression in adamantinoma. (21674157)
2011
16
Treatment of a large congenital melanocytic nevus with dermabrasion and autologous cell suspension (ReCELLAr): a case report. (21664206)
2011
17
Mifepristone (RU486), a pure antiprogesterone drug, in combination with vinblastine for the treatment of progesterone receptor-positive desmoid tumor. (20585823)
2010
18
Expression of placenta growth factor: an independent factor for prediction of progression and prognosis of oral cancer. (20091685)
2010
19
Chlorogenic acid protects paraoxonase 1 activity in high density lipoprotein from inactivation caused by physiological concentrations of hypochlorite. (19248222)
2009
20
Extraosseous Ewing's sarcoma: 25 years later. (18779607)
2008
21
Dithiolethiones for cancer chemoprevention: where do we stand? (19001432)
2008
22
Genetic variation of the FMR1 gene among four Mexican populations: Mestizo, Huichol, Purepecha, and Tarahumara. (18172867)
2008
23
Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran. (18990014)
2008
24
Extravasation of sclerosant after injection of N-butyl-2-cyanoacrylate for a bleeding gastric Dieulafoy lesion. (18633906)
2008
25
Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk. (18478343)
2008
26
Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. (18776739)
2008
27
Tuberin regulates the DNA repair enzyme OGG1. (17989114)
2008
28
B-mode and Doppler features of struma ovarii. (18098342)
2008
29
Expression of leptin and its receptor in female breast cancer in relation with selected apoptotic markers. (18292831)
2007
30
Another mutation in cysteine 131 in protein kinase C gamma as a cause of spinocerebellar ataxia type 14. (17562946)
2007
31
Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome. (16153625)
2006
32
Prenatal sonographic findings in Peters-plus syndrome. (15912477)
2005
33
Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells. (12706813)
2003
34
The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. (12271124)
2002
35
Obese premenopausal African-American women with normal and impaired glucose tolerance have a similar degree of insulin resistance but differ in beta-cell function. (11679468)
2001
36
Mast cells as initiators of immunity and host defense. (11168574)
2001
37
Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types. (10619912)
1999
38
Characterization of Bartonella henselae isolated from bacillary angiomatosis lesions in a human immunodeficiency virus-infected patient in Germany. (9636850)
1998
39
Phase I/IB study of polyadenylic-polyuridylic acid in patients with advanced malignancies: clinical and biologic effects. (8877734)
1996
40
Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty. (8812739)
1996
41
Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. (8937685)
1996
42
Functional diversity of LIM proteins: amino-terminal activation domains in the oncogenic proteins RBTN1 and RBTN2. (7731680)
1995
43
Relationship of familial prominent corneal nerves and lesions of the tongue resembling neuromas to multiple endocrine neoplasia type 2B. (7573303)
1995
44
FAP-1: a protein tyrosine phosphatase that associates with Fas. (7536343)
1995
45
p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. (8053492)
1994
46
Diagnosis and treatment of lymphomatoid granulomatosis. (1461861)
1992
47
Phosphorylation of a neuronal-specific beta-tubulin isotype. (2199448)
1990
48
Effects of gold sodium thiomalate and tenidap sodium (CP-66,248-2) on a model of macrophage differentiation using HL-60 cells. (2154231)
1990
49
Anosmia and isolated ACTH deficiency following a road traffic accident. Case report. (2166780)
1990
50
Lipoid proteinosis in two sisters. (7408724)
1980

Variations for Hypervitaminosis D

About this section

Expression for genes affiliated with Hypervitaminosis D

About this section
Search GEO for disease gene expression data for Hypervitaminosis D.

Pathways for genes affiliated with Hypervitaminosis D

About this section

Pathways related to Hypervitaminosis D according to GeneCards Suite gene sharing:

(show all 16)
idSuper pathwaysScoreTop Affiliating Genes
19.6FGF23, PTH
29.3CYP27B1, VDR
39.3CYP27B1, VDR
49.3CYP27B1, VDR
5
Show member pathways
9.3CYP27B1, VDR
69.3CYP27B1, VDR
79.3CYP27B1, VDR
89.3CYP27B1, VDR
99.3CYP27B1, VDR
109.3CYP27B1, VDR
11
Show member pathways
9.1FGF23, GALNT3
129.0CYP27B1, PTH, VDR
139.0CYP27B1, PTH, VDR
149.0CYP27B1, PTH, VDR
158.5CYP27B1, KL, TRPV5, VDR
16
Show member pathways
8.4CYP27B1, FGF23, KL, VDR

GO Terms for genes affiliated with Hypervitaminosis D

About this section

Biological processes related to Hypervitaminosis D according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1phosphatidylinositol-mediated signalingGO:00480159.8FGF23, KL
2vitamin D catabolic processGO:00423699.3CYP27B1, FGF23
3vitamin D metabolic processGO:00423599.2CYP27B1, FGF23
4response to vitamin DGO:00332809.2CYP27B1, PTH
5positive regulation of vitamin D 24-hydroxylase activityGO:00109808.9CYP27B1, FGF23, VDR

Sources for Hypervitaminosis D

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet